60% of Spaniards have a “high or very high” trust in pharmaceutical companies, according to Ipsos

Seven out of ten interviewees believe that laboratories will benefit from the Covid-19 crisis on a reputational level.

Two researchers.

60 percent of Spaniards claim to have a “high or very high” confidence in pharmaceutical laboratories. This is shown by a study prepared by Ipsos with the aim of knowing how the Covid-19 pandemic is impacting the image of pharmaceutical companies in Spain.

As a result of the health crisis, pharmaceutical companies have come to the fore today due to the important role they play in managing the pandemic, specifically in the manufacture of vaccines.

The pharmaceutical sector is having a beneficial return in terms of image, since seven out of 10 interviewees agree that laboratories will be favored on a reputational level of this crisis because of the fundamental role they are playing.

In addition, 60 percent of the surveyed Spaniards declare that they have high or very high confidence, with only 16 percent being those who trust very little in laboratories, and more than half (57%) consider that the pandemic will be overcome thanks to to them. But nevertheless, 42 percent believe that their image will not be reinforced, but it will be harmed by showing that its best interest is to earn money.

At the same time, 90 percent of those surveyed have assured that pharmaceutical companies will be the great beneficiaries of this crisis in economic terms, so they confess that they want to know more about the laboratories, or even demand that these companies share more information about them. and its activity.

Pharmaceutical companies

On the other hand, the study has shown that the companies that have vaccines are the best known and that are talked about on the internet and social networks. Specific, Pfizer ranks as the laboratory that is doing the best in this pandemic for 45 percent of those consulted, followed by Modern (18%) and PharmaMar (12%).

This “surge of favoritism” towards Pfizer is explained because it was the first laboratory to launch a vaccine and to obtain the support of the World Health Organization (WHO), as well as the international scientific community.

For its part, AstraZeneca, despite having a vaccine, is the worst rated in this sense, with only six percent of citizens who consider that it is the one that is best developing its work during the pandemic.